Geneyx offers a superior NGS data analysis and interpretation platform, harnessing genetic data to guide digital insights for rare and germline disorders. Our AI-based analysis platform streamlines the diagnostics process, from the raw genetic data to the final clinical report. Geneyx develops unique technologies and utilizes diverse databases in the interpretation of WGS (Whole Genome Sequencing), WES, and gene panels. We aim to enrich disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations.
Total Funding: N/A
Funding Stage: N/A
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: N/A
Oct 2020
- Geneyx Genomex Acquires NGS Sequencing Analysis Firm Toldot Genetics
Knowledge base backend developer
Senior Full Stack/Back End web developer
Marcom & Content Manager
